Plant Advanced Technologies SA

Research Plant Advanced Technologies SA (ALPAT) on Bullrun: market cap EUR 4.88M, P/E 8.4. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 4.88M; P/E is 8.4.

Peer valuation comparison

Latest P/E is 8.39x versus a Healthcare sector median of 24.46x (65.7% below).

Latest P/E is 8.39x versus a France median of 15.25x (45.0% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 1.14MEUR 569.40Kn/a109.4%n/aEUR 54.63KEUR 3.74MEUR 9.84M
FY2024EUR 1.93MEUR 935.13KEUR 2.08M116.0%n/aEUR 79.70KEUR 3.51MEUR 9.17M
FY2023EUR 1.68MEUR 79.17KEUR 972.53K128.0%0.07n/aEUR 4.36MEUR 8.13M
FY2022EUR 1.55M-EUR 402.54K-EUR 2.26K130.9%-0.36EUR 4.68KEUR 5.04MEUR 8.06M
FY2021EUR 1.54M-EUR 868.29K-EUR 1.57K133.6%-0.8EUR 388.34KEUR 4.68MEUR 8.46M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-27EUR 4.88M8.4n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Plant Advanced Technologies SA

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies SA was incorporated in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Plant Advanced Technologies SA's market cap?

Plant Advanced Technologies SA's market capitalization is EUR 4.88M.

What is Plant Advanced Technologies SA's P/E ratio?

Plant Advanced Technologies SA's price-to-earnings (P/E) ratio is 8.4.

What does Plant Advanced Technologies SA do?

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies SA was incorporated in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.